image
Healthcare - Biotechnology - NASDAQ - US
$ 4.73
-3.27 %
$ 52.5 M
Market Cap
-5.77
P/E
CASH FLOW STATEMENT
-3.53 M OPERATING CASH FLOW
-18.09%
-51.8 K INVESTING CASH FLOW
34.73%
2.09 M FINANCING CASH FLOW
1203.63%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Nutriband Inc.
image
Net Income -5.49 M
Depreciation & Amortization 288 K
Capital Expenditures -51.8 K
Stock-Based Compensation 743 K
Change in Working Capital 223 K
Others 822 K
Free Cash Flow -3.58 M

Cash Flow

Millions
Jan-2024 Jan-2023 Jan-2022 Jan-2021 Jan-2020 Jan-2019 Jan-2018 Jan-2017 Jan-2016
OPERATING CASH FLOW
Net Income (5.5) (4.5) (6.2) (2.9) (2.7) (3.3) (2.7) (0.2) 400
Depreciation & Amortization 0.3 0.4 0.3 0.2 91.4 K 37 K 0 0 0
Deferred Income Tax 0 0 0 12.9 K 0.7 0 0 0 0
Stock Based Compensation 0.7 0.7 0.9 2.0 0.3 1.8 0 7.77 K 0
Other Operating Activities 0.7 0.6 2.2 0.4 91.3 K 24.3 K 2.5 15.8 K 4.8 K
Change in Working Capital 0.2 (0.2) (0.5) 0.1 0.7 0.4 75.1 K 4.43 K 400
Cash From Operations (3.5) (3.0) (2.8) (0.3) (0.9) (1.1) 92.9 K (0.1) 0
INVESTING CASH FLOW
Capital Expenditures 51.8 K 79.3 K 81.6 K 0 0 4.16 K 0 0 0
Other Items 0 0 0 67 K 0 (0.4) 92.9 K 0 0
Cash From Investing Activities 51.8 K 79.3 K 81.6 K 67 K 0 (0.4) 92.9 K 0 0
FINANCING CASH FLOW
Common Stock Repurchased 0 (0.1) (0.1) 0 0 0 0 0 0
Total Debt Repaid 2.1 17.8 K (1.6) (0.2) 0.4 22.4 K 7.51 K 0 100
Dividends Paid 0 0 (0.2) 0 0 0 0 0 0
Other Financing Activities 1 0.3 3.1 18.3 K 5.25 K 0.5 8.25 K 100 0
Cash From Financing Activities 2.1 0.2 7.6 0.4 0.4 2.0 65.8 K 0.2 100
CHANGE IN CASH
Net Change In Cash (1.5) (2.9) 4.7 0.1 (0.5) 0.5 65.8 K 27 K 100
FREE CASH FLOW
Free Cash Flow (3.6) (3.1) (2.9) (0.3) (0.9) (1.1) 92.9 K (0.1) 0